MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA)

Historical Holders from Q4 2020 to Q3 2025

Symbol
HLXA
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
181,600
Holdings value
$1,302,072
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 181,600 $1,302,072 $7.17 1
2025 Q2 181,600 $8,571,520 +$472,000 $47.2 1
2025 Q1 171,600 $6,704,412 $39.07 1
2024 Q4 171,600 $9,292,140 +$270,750 $54.15 1
2024 Q3 166,600 $8,399,972 $50.42 1
2024 Q2 166,600 $7,325,402 $43.97 1
2024 Q1 166,600 $8,368,318 +$8,368,318 $50.23 1
2022 Q2 0 $0 -$116,191,000 0
2022 Q1 10,912,791 $116,191,000 -$3,240,021 $11.1 26
2021 Q4 11,425,219 $112,817,466 +$259,064 $9.89 45
2021 Q3 11,218,564 $111,066,000 +$196,114 $9.89 43
2021 Q2 11,194,065 $115,764,000 +$5,400,505 $10.35 45
2021 Q1 10,667,865 $108,909,000 -$2,638,131 $10.2 42
2020 Q4 10,908,299 $122,413,000 +$109,677,000 $11.37 44